The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Serum (Blood) Market Research Report 2025

Global Serum (Blood) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1555911

No of Pages : 101

Ask Your Query

Synopsis

The global Serum (Blood) market was valued at US$ 1015.4 million in 2023 and is anticipated to reach US$ 1407.2 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Serum (Blood), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum (Blood).

Report Scope

The Serum (Blood) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Serum (Blood) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Serum (Blood) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Thermo Fisher (Life-Tech)
  • Sigma-Aldrich
  • Merck
  • Corning
  • Bovogen
  • Moregate Biotech
  • Biowest
  • Gemini
  • Bioind
  • Tissue Culture Biologicals
  • Animal Technologies
  • South Pacific Sera
  • Lanzhou Minhai
  • Changchun Xinuo
  • Wuhan Sanli

Segment by Type

  • Bovine Serum
  • FBS
  • Segment by Application
  • Biological Products
  • Research

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Serum (Blood) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Serum (Blood) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Serum (Blood) Market Overview
1.1 Product Overview and Scope of Serum (Blood)
1.2 Serum (Blood) Segment by Type
1.2.1 Global Serum (Blood) Market Value Comparison by Type (2024-2030)
1.2.2 Bovine Serum
1.2.3 FBS
1.3 Serum (Blood) Segment by Application
1.3.1 Global Serum (Blood) Market Value by Application: (2024-2030)
1.3.2 Biological Products
1.3.3 Research
1.4 Global Serum (Blood) Market Size Estimates and Forecasts
1.4.1 Global Serum (Blood) Revenue 2019-2030
1.4.2 Global Serum (Blood) Sales 2019-2030
1.4.3 Global Serum (Blood) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Serum (Blood) Market Competition by Manufacturers
2.1 Global Serum (Blood) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Serum (Blood) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Serum (Blood) Average Price by Manufacturers (2019-2024)
2.4 Global Serum (Blood) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Serum (Blood), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Serum (Blood), Product Type & Application
2.7 Serum (Blood) Market Competitive Situation and Trends
2.7.1 Serum (Blood) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Serum (Blood) Players Market Share by Revenue
2.7.3 Global Serum (Blood) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Serum (Blood) Retrospective Market Scenario by Region
3.1 Global Serum (Blood) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Serum (Blood) Global Serum (Blood) Sales by Region: 2019-2030
3.2.1 Global Serum (Blood) Sales by Region: 2019-2024
3.2.2 Global Serum (Blood) Sales by Region: 2025-2030
3.3 Global Serum (Blood) Global Serum (Blood) Revenue by Region: 2019-2030
3.3.1 Global Serum (Blood) Revenue by Region: 2019-2024
3.3.2 Global Serum (Blood) Revenue by Region: 2025-2030
3.4 North America Serum (Blood) Market Facts & Figures by Country
3.4.1 North America Serum (Blood) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Serum (Blood) Sales by Country (2019-2030)
3.4.3 North America Serum (Blood) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Serum (Blood) Market Facts & Figures by Country
3.5.1 Europe Serum (Blood) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Serum (Blood) Sales by Country (2019-2030)
3.5.3 Europe Serum (Blood) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Serum (Blood) Market Facts & Figures by Country
3.6.1 Asia Pacific Serum (Blood) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Serum (Blood) Sales by Country (2019-2030)
3.6.3 Asia Pacific Serum (Blood) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Serum (Blood) Market Facts & Figures by Country
3.7.1 Latin America Serum (Blood) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Serum (Blood) Sales by Country (2019-2030)
3.7.3 Latin America Serum (Blood) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Serum (Blood) Market Facts & Figures by Country
3.8.1 Middle East and Africa Serum (Blood) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Serum (Blood) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Serum (Blood) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Serum (Blood) Sales by Type (2019-2030)
4.1.1 Global Serum (Blood) Sales by Type (2019-2024)
4.1.2 Global Serum (Blood) Sales by Type (2025-2030)
4.1.3 Global Serum (Blood) Sales Market Share by Type (2019-2030)
4.2 Global Serum (Blood) Revenue by Type (2019-2030)
4.2.1 Global Serum (Blood) Revenue by Type (2019-2024)
4.2.2 Global Serum (Blood) Revenue by Type (2025-2030)
4.2.3 Global Serum (Blood) Revenue Market Share by Type (2019-2030)
4.3 Global Serum (Blood) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Serum (Blood) Sales by Application (2019-2030)
5.1.1 Global Serum (Blood) Sales by Application (2019-2024)
5.1.2 Global Serum (Blood) Sales by Application (2025-2030)
5.1.3 Global Serum (Blood) Sales Market Share by Application (2019-2030)
5.2 Global Serum (Blood) Revenue by Application (2019-2030)
5.2.1 Global Serum (Blood) Revenue by Application (2019-2024)
5.2.2 Global Serum (Blood) Revenue by Application (2025-2030)
5.2.3 Global Serum (Blood) Revenue Market Share by Application (2019-2030)
5.3 Global Serum (Blood) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher (Life-Tech)
6.1.1 Thermo Fisher (Life-Tech) Corporation Information
6.1.2 Thermo Fisher (Life-Tech) Description and Business Overview
6.1.3 Thermo Fisher (Life-Tech) Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher (Life-Tech) Serum (Blood) Product Portfolio
6.1.5 Thermo Fisher (Life-Tech) Recent Developments/Updates
6.2 Sigma-Aldrich
6.2.1 Sigma-Aldrich Corporation Information
6.2.2 Sigma-Aldrich Description and Business Overview
6.2.3 Sigma-Aldrich Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sigma-Aldrich Serum (Blood) Product Portfolio
6.2.5 Sigma-Aldrich Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Serum (Blood) Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Corning
6.4.1 Corning Corporation Information
6.4.2 Corning Description and Business Overview
6.4.3 Corning Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Corning Serum (Blood) Product Portfolio
6.4.5 Corning Recent Developments/Updates
6.5 Bovogen
6.5.1 Bovogen Corporation Information
6.5.2 Bovogen Description and Business Overview
6.5.3 Bovogen Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bovogen Serum (Blood) Product Portfolio
6.5.5 Bovogen Recent Developments/Updates
6.6 Moregate Biotech
6.6.1 Moregate Biotech Corporation Information
6.6.2 Moregate Biotech Description and Business Overview
6.6.3 Moregate Biotech Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Moregate Biotech Serum (Blood) Product Portfolio
6.6.5 Moregate Biotech Recent Developments/Updates
6.7 Biowest
6.6.1 Biowest Corporation Information
6.6.2 Biowest Description and Business Overview
6.6.3 Biowest Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biowest Serum (Blood) Product Portfolio
6.7.5 Biowest Recent Developments/Updates
6.8 Gemini
6.8.1 Gemini Corporation Information
6.8.2 Gemini Description and Business Overview
6.8.3 Gemini Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Gemini Serum (Blood) Product Portfolio
6.8.5 Gemini Recent Developments/Updates
6.9 Bioind
6.9.1 Bioind Corporation Information
6.9.2 Bioind Description and Business Overview
6.9.3 Bioind Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bioind Serum (Blood) Product Portfolio
6.9.5 Bioind Recent Developments/Updates
6.10 Tissue Culture Biologicals
6.10.1 Tissue Culture Biologicals Corporation Information
6.10.2 Tissue Culture Biologicals Description and Business Overview
6.10.3 Tissue Culture Biologicals Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tissue Culture Biologicals Serum (Blood) Product Portfolio
6.10.5 Tissue Culture Biologicals Recent Developments/Updates
6.11 Animal Technologies
6.11.1 Animal Technologies Corporation Information
6.11.2 Animal Technologies Serum (Blood) Description and Business Overview
6.11.3 Animal Technologies Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Animal Technologies Serum (Blood) Product Portfolio
6.11.5 Animal Technologies Recent Developments/Updates
6.12 South Pacific Sera
6.12.1 South Pacific Sera Corporation Information
6.12.2 South Pacific Sera Serum (Blood) Description and Business Overview
6.12.3 South Pacific Sera Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 South Pacific Sera Serum (Blood) Product Portfolio
6.12.5 South Pacific Sera Recent Developments/Updates
6.13 Lanzhou Minhai
6.13.1 Lanzhou Minhai Corporation Information
6.13.2 Lanzhou Minhai Serum (Blood) Description and Business Overview
6.13.3 Lanzhou Minhai Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lanzhou Minhai Serum (Blood) Product Portfolio
6.13.5 Lanzhou Minhai Recent Developments/Updates
6.14 Changchun Xinuo
6.14.1 Changchun Xinuo Corporation Information
6.14.2 Changchun Xinuo Serum (Blood) Description and Business Overview
6.14.3 Changchun Xinuo Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Changchun Xinuo Serum (Blood) Product Portfolio
6.14.5 Changchun Xinuo Recent Developments/Updates
6.15 Wuhan Sanli
6.15.1 Wuhan Sanli Corporation Information
6.15.2 Wuhan Sanli Serum (Blood) Description and Business Overview
6.15.3 Wuhan Sanli Serum (Blood) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Wuhan Sanli Serum (Blood) Product Portfolio
6.15.5 Wuhan Sanli Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Serum (Blood) Industry Chain Analysis
7.2 Serum (Blood) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Serum (Blood) Production Mode & Process
7.4 Serum (Blood) Sales and Marketing
7.4.1 Serum (Blood) Sales Channels
7.4.2 Serum (Blood) Distributors
7.5 Serum (Blood) Customers
8 Serum (Blood) Market Dynamics
8.1 Serum (Blood) Industry Trends
8.2 Serum (Blood) Market Drivers
8.3 Serum (Blood) Market Challenges
8.4 Serum (Blood) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock